Login / Signup

Risk and Benefit of Antiplatelet Therapy in COVID-19 Patients with Cancer and Thrombocytopenia: Letter to the Editor.

Hassan NourmohammadiGolnaz AzamiFakhredin TaghinezhadElham Shafiei
Published in: Cancer investigation (2021)
Keyphrases
  • antiplatelet therapy
  • acute coronary syndrome
  • percutaneous coronary intervention
  • coronavirus disease
  • sars cov
  • coronary artery disease
  • atrial fibrillation